HHG & Company’s Bristol-Myers Squibb BMY Stock Holding History

HHG & Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$3.3M	Sell	51,611 -523	-1%	-$33K	0.92%	25
2015 Q4	$3.59M	Sell	52,134 -500	-0.9%	-$33K	0.97%	22
2015 Q3	$3.12M	Hold	52,634	–	–	0.95%	24
2015 Q2	$3.5M	Sell	52,634 -30	-0.1%	-$1.98K	1.01%	20
2015 Q1	$3.4M	Buy	52,664 +214	+0.4%	+$13.4K	0.89%	25
2014 Q4	$3.1M	Buy	52,450 +200	+0.4%	+$11.3K	0.74%	28
2014 Q3	$2.67M	Buy	52,250 +1,250	+2%	+$62.4K	0.87%	25
2014 Q2	$2.47M	Hold	51,000	–	–	0.81%	40
2014 Q1	$2.65M	Hold	51,000	–	–	0.9%	34
2013 Q4	$2.71M	Sell	51,000 -284	-0.6%	-$14.5K	1%	26
2013 Q3	$2.37M	Buy	51,284 +236	+0.5%	+$10.4K	0.95%	27
2013 Q2	$2.28M	Buy	+51,048	New	+$2.22M	0.92%	26

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HHG & Company's BMY Position: Q1 2016 in Review

HHG & Company reduced its Bristol-Myers Squibb (BMY) stake by 1% in Q1 2016, selling an estimated $33K and leaving 51,611 shares worth $3.3M. The position accounts for 0.92% of the portfolio, ranked #25.

HHG & Company first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. The position peaked at $3.59M in Q4 2015. 1,524 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

HHG & Company held 51,611 shares of Bristol-Myers Squibb worth $3.3M as of Q1 2016.
HHG & Company sold 523 Bristol-Myers Squibb shares in Q1 2016, an estimated $33K.
Bristol-Myers Squibb made up 0.92% of HHG & Company's portfolio in Q1 2016, its #25 holding.
HHG & Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
HHG & Company's Bristol-Myers Squibb position peaked at $3.59M in Q4 2015.
1,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on HHG & Company's 13F filing for Q1 2016, filed 20 Apr 2016.